Jacobs Levy Equity Management’s Zymeworks ZYME Stock Holding History

Jacobs Levy Equity Management’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$965K	Sell	36,922 -5,864	-14%	-$149K	﹤0.01%	716
2026 Q1	$1.07M	Buy	+42,786	New	+$1.01M	﹤0.01%	692
2025 Q2	–	Sell	-12,040	Closed	-$143K	–	1188
2025 Q1	$143K	Sell	12,040 -344,128	-97%	-$4.69M	﹤0.01%	1038
2024 Q4	$5.21M	Sell	356,168 -166,472	-32%	-$2.33M	0.02%	424
2024 Q3	$6.56M	Sell	522,640 -129,088	-20%	-$1.41M	0.03%	393
2024 Q2	$5.55M	Sell	651,728 -64,754	-9%	-$576K	0.02%	440
2024 Q1	$7.54M	Buy	716,482 +348,441	+95%	+$3.87M	0.03%	348
2023 Q4	$3.82M	Buy	368,041 +304,040	+475%	+$2.42M	0.02%	483
2023 Q3	$406K	Sell	64,001 -115,895	-64%	-$856K	﹤0.01%	838
2023 Q2	$1.55M	Buy	+179,896	New	+$1.61M	0.01%	617

Other funds holding ZYME

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

Jacobs Levy Equity Management's ZYME Position: Q2 2026 in Review

Jacobs Levy Equity Management reduced its Zymeworks (ZYME) stake by 14% in Q2 2026, selling an estimated $149K and leaving 36,922 shares worth $965K. The position accounts for ﹤0.01% of the portfolio, ranked #716.

Jacobs Levy Equity Management first reported a position in ZYME in Q2 2023 and has held it in 10 quarters since. The position peaked at $7.54M in Q1 2024. 202 funds tracked by Wall St. Rank hold ZYME as of Q2 2026.

Jacobs Levy Equity Management held 36,922 shares of Zymeworks worth $965K as of Q2 2026.
Jacobs Levy Equity Management sold 5,864 Zymeworks shares in Q2 2026, an estimated $149K.
Zymeworks made up ﹤0.01% of Jacobs Levy Equity Management's portfolio in Q2 2026, its #716 holding.
Jacobs Levy Equity Management first reported a position in Zymeworks in Q2 2023 and has held it in 10 quarters since.
Jacobs Levy Equity Management's Zymeworks position peaked at $7.54M in Q1 2024.
202 funds tracked by Wall St. Rank held Zymeworks as of Q2 2026.

Based on Jacobs Levy Equity Management's 13F filing for Q2 2026, filed 14 Aug 2026.